Literature DB >> 23750450

Isolation and first total synthesis of PM050489 and PM060184, two new marine anticancer compounds.

María Jesús Martín1, Laura Coello, Rogelio Fernández, Fernando Reyes, Alberto Rodríguez, Carmen Murcia, María Garranzo, Cristina Mateo, Francisco Sánchez-Sancho, Santiago Bueno, Carlos de Eguilior, Andrés Francesch, Simon Munt, Carmen Cuevas.   

Abstract

Microtubules continue to be one of the most successful anticancer drug targets and a favorite hit for many naturally occurring molecules. While two of the most successful representative agents in clinical use, the taxanes and the vinca alkaloids, come from terrestrial sources, the sea has also proven to be a rich source of new tubulin-binding molecules. We describe herein the first isolation, structural elucidation and total synthesis of two totally new polyketides isolated from the Madagascan sponge Lithoplocamia lithistoides . Both PM050489 and PM060184 show antimitotic properties in human tumor cells lines at subnanomolar concentrations and display a distinct inhibition mechanism on microtubules. The development of an efficient synthetic procedure has solved the supply problem and, following pharmaceutical development, has allowed PM060184 to start clinical studies as a promising new drug for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750450     DOI: 10.1021/ja404578u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  20 in total

Review 1.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

2.  A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.

Authors:  Andrea E Prota; Katja Bargsten; J Fernando Diaz; May Marsh; Carmen Cuevas; Marc Liniger; Christian Neuhaus; Jose M Andreu; Karl-Heinz Altmann; Michel O Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

3.  First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.

Authors:  Elena Elez; Carlos Gomez-Roca; Arturo Soto Matos-Pita; Guillem Argiles; Thibaud Valentin; Cinthya Coronado; Jorge Iglesias; Teresa Macarulla; Sarah Betrian; Salvador Fudio; Katrin Zaragoza; Josep Tabernero; Jean-Pierre Delord
Journal:  Invest New Drugs       Date:  2018-11-09       Impact factor: 3.850

Review 4.  Enriching cancer pharmacology with drugs of marine origin.

Authors:  Paula C Jimenez; Diego V Wilke; Paola C Branco; Anelize Bauermeister; Paula Rezende-Teixeira; Susana P Gaudêncio; Leticia V Costa-Lotufo
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

5.  Isomerization of N-Allyl Amides To Form Geometrically Defined Di-, Tri-, and Tetrasubstituted Enamides.

Authors:  Barry M Trost; James J Cregg; Nicolas Quach
Journal:  J Am Chem Soc       Date:  2017-04-04       Impact factor: 15.419

Review 6.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

7.  Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.

Authors:  Ana Zovko; Metka Novak; Petra Hååg; Dimitry Kovalerchick; Teresa Holmlund; Katarina Färnegårdh; Micha Ilan; Shmuel Carmeli; Rolf Lewensohn; Kristina Viktorsson
Journal:  Oncotarget       Date:  2016-08-02

Review 8.  Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development.

Authors:  David J Newman; Gordon M Cragg
Journal:  Mar Drugs       Date:  2014-01-14       Impact factor: 5.118

Review 9.  Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".

Authors:  Nelson G M Gomes; Ramesh Dasari; Sunena Chandra; Robert Kiss; Alexander Kornienko
Journal:  Mar Drugs       Date:  2016-05-21       Impact factor: 5.118

10.  Field sampling marine plankton for biodiscovery.

Authors:  Richard Andre Ingebrigtsen; Espen Hansen; Jeanette Hammer Andersen; Hans Christian Eilertsen
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.